Although a variety of nanoparticles continue to show promise for improving cancer imaging and therapy, regulators and drug developers are concerned that these delivery systems may prove difficult to manufacture on a consistent basis, which is key for any agent designed for use in humans. A new study provides data showing that such concerns can be overcome.
Brain cancer is one of the most aggressive and lethal of malignancies, made even more difficult to treat by the fact that most anticancer drugs have a hard time even getting to the tumors. Now, studies by three different groups of researchers show that targeted nanoparticles hold promise for solving this delivery problem.
Carbon nanotubes have shown real promise as highly accurate vehicles for delivering antitumor agents into malignant cells, but a dearth of data about what happens to the tubes after they discharge their medical payloads has been a major stumbling block to progress. Now, two studies at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response have revealed some reassuring answers after months of tracking the tiny tubes inside mice.
Next Monday, February 18, 2008, the Innovation Ministry of the German federal state North Rhine-Westphalia (NRW) will kick off the 1st NRW-Nanokonferenz (in German) in Dortmund with a EUR61 million (approx. $85 million) endowed competition for scientists and entrepreneurs.
Recently published research has established the ability of Neowater to enhance the various processes involved in the production of pure human monoclonal antibodies by refining the standard hybridoma production process.
During opening testimony before the House Appropriations Subcommittee on Energy and Water Development, Argonne's Don Hillebrand noted that while the United States is the dominant player in the development of battery materials and chemistries for hybrid vehicles and Plug-in Hybrid Electric Vehicles (PHEV) with the help of progressive research conducted at U.S. Department of Energy national laboratories, including Argonne, the nation lags behind the world in adopting capabilities to make such batteries.
he Roy J. Carver Charitable Trust of Muscatine, Iowa has made a $1 million grant to support the University Iowa's acquisition of a field emission transmission electron microscope (FETEM) that will advance biomedical and physical science research and education at the UI.
Instead of trying to produce energy without creating CO2 gases, researchers are looking for a way to sequester the greenhouse gases that are produced at the source so they don't reach the atmosphere, literally creating a kind of chemical filter for, say, a coal power plant.
Here is our Slow News Friday story for today. Nano Pet Products, LLC, a company dedicated to bringing cleaner and healthier pet products to pet owners worldwide through nanotechnology, debuts its Dog Gone Smart Wear brand dog apparel.
To recognize the continuing contributions that Scanning Probe Microscopes (SPMs) have made to advances in Nanotechnology, an International SPM Image Competition last year identified important and remarkable SPM images.
The Laboratory of Metal Physics and Technology, Department of Materials at the ETH Zurich (Swiss Federal Institute of Technology) is looking for one postdoc and two Ph.D. candidates interested in nano-optics and surface-enhanced Raman spectroscopy (SERS).
Scientists from the University of Reading have discovered that proteins stick, slide and cluster on solid surfaces. The way in which proteins cluster on a surface affects their activity and the findings from this research will help to develop new materials for use in medical and dental implants.
Liming Dai, a University of Dayton chemical and materials engineering professor, and Yiling Hong, a UD assistant biology professor have made a breakthrough in determining the safety of microscopic carbon materials sometimes used for gene, drug or cancer therapies.